Basilea Pharmaceutica AG (SWX:BSLN)

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Discovery, Development & Commercialization of Innovative Pharmaceutical Products	232.38M	208.54M	157.63M	147.77M	148.12M
Discovery, Development & Commercialization of Innovative Pharmaceutical Products Growth	11.43%	32.30%	6.68%	-0.24%	16.06%
Total	232.38M	208.54M	157.63M	147.77M	148.12M
Total Growth	11.43%	32.30%	6.68%	-0.24%	16.06%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Japan	86.60M	69.60M	59.60M	64.00M	56.50M
Japan Growth	24.43%	16.78%	-6.87%	13.27%	40.90%
Ireland	78.10M	93.70M	68.70M	41.30M	62.10M
Ireland Growth	-16.65%	36.39%	66.34%	-33.49%	9.14%
USA	37.00M	12.30M	6.10M	9.80M	14.50M
USA Growth	200.81%	101.64%	-37.76%	-32.41%	9.85%
Uruguay	8.70M	12.10M	10.20M	7.40M	3.40M
Uruguay Growth	-28.10%	18.63%	37.84%	117.65%	-29.17%
China	6.70M	2.30M	2.30M	100.00K	-
China Growth	191.30%	0%	2200.00%	-	-
Other	15.30M	18.50M	-	600.00K	700.00K
Other Growth	-17.30%	-	-	-14.29%	-84.09%
Switzerland	-	-	-	2.40M	3.70M
Switzerland Growth	-	-	-	-35.14%	-
Canada	-	-	3.60M	2.80M	2.20M
Canada Growth	-	-	28.57%	27.27%	-
Jordan	-	-	1.80M	2.70M	2.20M
Jordan Growth	-	-	-33.33%	22.73%	-
United Kingdom	-	-	1.40M	-	-
Sweden	-	-	3.90M	3.20M	2.80M
Sweden Growth	-	-	21.88%	14.29%	-3.45%
Republic of Korea	-	-	-	13.50M	-
Total	232.40M	208.50M	157.60M	147.80M	148.10M
Total Growth	11.46%	32.30%	6.63%	-0.20%	16.07%

Source: S&P Global Market Intelligence.